{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:38:51Z","timestamp":1790419131763,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.jcv.2005.03.005","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T01:40:42Z","timestamp":1116121242000},"page":"170-178","source":"Crossref","is-referenced-by-count":38,"title":["Expanding the frontiers of existing antiviral drugs: Possible effects of HIV-1 protease inhibitors against SARS and avian influenza"],"prefix":"10.1016","volume":"34","author":[{"given":"Andrea","family":"Savarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2005.03.005_bib1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jcv.2005.03.005_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/314871","article-title":"In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors","volume":"180","author":"Cassone","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2005.03.005_bib3","first-page":"399","article-title":"Treatment of severe acute respiratory syndrome with lopinavir\/ritonavir: a multicentre retrospective matched cohort study","volume":"9","author":"Chan","year":"2003","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.jcv.2005.03.005_bib4","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1086\/386340","article-title":"Consideration of highly active antiretroviral therapy in the prevention and treatment of severe acute respiratory syndrome","volume":"38","author":"Chen","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2005.03.005_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00126334-200310010-00016","article-title":"Lack of severe acute respiratory syndrome in 19 AIDS patients hospitalised together","volume":"34","author":"Chen","year":"2003","journal-title":"J Acquir Immun Defic Syndr"},{"key":"10.1016\/j.jcv.2005.03.005_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","article-title":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds","volume":"31","author":"Chen","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2005.03.005_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jinf.2004.07.010","article-title":"Medical treatment of viral pneumonia including SARS in immunocompetent adult","volume":"49","author":"Cheng","year":"2004","journal-title":"J Infect"},{"key":"10.1016\/j.jcv.2005.03.005_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jcv.2005.03.005_bib9","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcv.2005.03.005_bib10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1074\/jbc.M310875200","article-title":"Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase","volume":"279","author":"Fan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcv.2005.03.005_bib11","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1128\/JVI.76.18.8989-9001.2002","article-title":"A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs","volume":"76","author":"Fodor","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2005.03.005_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2443.2001.00399.x","article-title":"Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site","volume":"6","author":"Hara","year":"2001","journal-title":"Genes Cells"},{"key":"10.1016\/j.jcv.2005.03.005_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0531-5131(01)00642-2","article-title":"Protease activity of influenza virus RNA polymerase PA subunit","volume":"1219","author":"Hara","year":"2001","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.jcv.2005.03.005_bib14","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1016\/j.bmcl.2003.08.066","article-title":"Identifying inhibitors of the SARS coronavirus proteinase","volume":"13","author":"Jenwitheesuk","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jcv.2005.03.005_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6807-3-2","article-title":"Improved prediction of HIV-1 protease-inhibitors binding energies by molecular dynamics simulations","volume":"3","author":"Jenwitheesuk","year":"2003","journal-title":"BMC Struct Biol"},{"key":"10.1016\/j.jcv.2005.03.005_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcv.2005.03.005_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/embo-reports\/kve063","article-title":"Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle","volume":"2","author":"Mart\u00edn-Benito","year":"2001","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jcv.2005.03.005_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00002030-200203290-00004","article-title":"The human 26S proteasome is a target of antiretroviral agents","volume":"16","author":"Piccinini","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2005.03.005_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1386-6532(00)00139-6","article-title":"The anti-HIV-1 activity of chloroquine","volume":"20","author":"Savarino","year":"2001","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2005.03.005_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine in viral infections: an old drug against today's diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcv.2005.03.005_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00126334-200403010-00002","article-title":"Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors","volume":"35","author":"Savarino","year":"2004","journal-title":"J Acquir Defic Syndr"},{"key":"10.1016\/j.jcv.2005.03.005_bib22","unstructured":"Savarino A, Sannella A, Spaccapelo R, Lucia MB, Severini C, Boelaert JR, et al. HIV-1 protease inhibitors exert antimalarial effects both in vitro and in vivo and partially revert Plasmodium falciparum resistance to chloroquine in vitro. Med Gen Med 2004b;6:ThPeA6940 [eJIAS. 2004 Jul 11;1(1):ThPeA6940]."},{"key":"10.1016\/j.jcv.2005.03.005_bib23","unstructured":"Savarino A, Cauda R, Cassone A. Aspartic proteases of Plasmodium falciparum as target of HIV protease inhibitors. J Infect Dis, in press."},{"key":"10.1016\/j.jcv.2005.03.005_bib24","doi-asserted-by":"crossref","first-page":"35734","DOI":"10.1074\/jbc.274.50.35734","article-title":"How an inhibitor of the HIV-1 protease modulates proteasome activity","volume":"274","author":"Schmidtke","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcv.2005.03.005_bib25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bbrc.2004.09.088","article-title":"A novel auto-cleavage assay for studying mutational effects of the active site of severe acute respiratory syndrome coronavirus 3C-like protease","volume":"324","author":"Shan","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcv.2005.03.005_bib26","doi-asserted-by":"crossref","first-page":"24765","DOI":"10.1074\/jbc.M311744200","article-title":"Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors","volume":"279","author":"Shi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcv.2005.03.005_bib27","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/382597","article-title":"Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha","volume":"189","author":"Stroher","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2005.03.005_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pep.2003.08.016","article-title":"Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus","volume":"32","author":"Sun","year":"2003","journal-title":"Protein Exp Purif"},{"key":"10.1016\/j.jcv.2005.03.005_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1568013043483211","article-title":"Candidiasis and HIV-protease inhibitors: the expected and unexpected","volume":"4","author":"Tacconelli","year":"2004","journal-title":"Curr Med Chem Immunol Endocr Metab Agents"},{"key":"10.1016\/j.jcv.2005.03.005_bib30","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00705-003-0140-7","article-title":"Ser624 of the PA subunit of influenza A virus is not essential for viral growth in cells and mice, but required for the maximal viral growth","volume":"148","author":"Toyoda","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.jcv.2005.03.005_bib31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbrc.2004.04.083","article-title":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus","volume":"318","author":"Yamamoto","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcv.2005.03.005_bib32","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.jcv.2005.03.005_bib33","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.bmc.2004.03.035","article-title":"Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs","volume":"12","author":"Zhang","year":"2004","journal-title":"Bioorg Med Chem"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653205000880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653205000880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T08:26:45Z","timestamp":1548491205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653205000880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1386653205000880"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2005.03.005","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}